Evidence map›Paper›PMID 29165041›Full record

ArticleAutophagy2018

AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells.

Zhenhong Ni, Jintao He, Yaran Wu, Changjiang Hu, Xufang Dai, Xiaojing Yan, Bo Li, Xinzhe Li, Haojun Xiong, Yuming Li and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Zhenhong Nia Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Jintao Heb Battalion 17 of Students , College of Preventive Medicine, Third Military Medical University , Chongqing, China.
Yaran Wua Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Changjiang Huc Department of Gastroenterology , Xinqiao Hospital, Third Military Medical University , Chongqing , China.
Xufang Daid College of Educational Science, Chongqing Normal University , Chongqing , China.
Xiaojing Yana Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Bo Lia Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Xinzhe Lia Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Haojun Xionga Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Yuming Lie Department of Hepatobiliary Surgery , Xinqiao Hospital, Third Military Medical University , Chongqing , China.
Song Lif Center for Pharmacogenetics , Department of Pharmaceutical Sciences, School of Pharmacy , University of Pittsburgh , Pittsburgh , PA , USA.
Liang Xug Department of Molecular Biosciences and Department of Radiation Oncology , University of Kansas Cancer Center, University of Kansas , Lawrence , KS , USA.
Yongsheng Lih Institute of Cancer, Xinqiao Hospital, Third Military Medical University , Chongqing , China.
Jiqin Liana Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Fengtian Hea Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
Army Medical University · CNXinqiao Hospital · CNChongqing Normal University · CNThe University of Kansas Cancer Center · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphorylation is a major type of post-translational modification, which can influence the cellular physiological function. ATG4B, a key macroautophagy/autophagy-related protein, has a potential effect on the survival of tumor cells. However, the role of ATG4B phosphorylation in cancers is still unknown. In this study, we identified a novel phosphorylation site at Ser34 of ATG4B induced by AKT in HCC cells. The phosphorylation of ATG4B at Ser34 had little effect on autophagic flux, but promoted the Warburg effect including the increase of L-lactate production and glucose consumption, and the decrease of oxygen consumption in HCC cells. The Ser34 phosphorylation of ATG4B also contributed to the impairment of mitochondrial activity including the inhibition of F

Indexed as

Autophagy-Related ProteinsCarcinoma, HepatocellularCell Line, TumorCell SurvivalCysteine EndopeptidasesGlucoseHumansLiver NeoplasmsMitochondriaPhosphorylationProto-Oncogene Proteins c-aktATG4B protein, humanAutophagy-Related ProteinsCysteine EndopeptidasesGlucoseProto-Oncogene Proteins c-aktAKTATG4BF1Fo-ATP synthaseHCCphosphorylationWarburg effect

Identifiers

PMID29165041
PMCPMC5959332
OpenAlexW2768796521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.